Clinical Trials Logo

Implant Complication clinical trials

View clinical trials related to Implant Complication.

Filter by:

NCT ID: NCT05361980 Recruiting - Pediatric ALL Clinical Trials

Pediatric Orthopaedic Implant Safety & Efficacy

Global POISE
Start date: January 6, 2022
Phase:
Study type: Observational [Patient Registry]

Implant devices are important tools - their use is essential across a number of orthopaedic indications, including hip conditions, trauma and limb deformity. Given the vital role fixation devices play in maintaining alignment, promoting healthy bone healing and preventing joint degeneration, it is essential to understand the expected lifetime outcomes of these implants, and evaluate their safety and efficacy. Prospective implant efficacy and safety registries are needed to support this endeavour, especially considering new regulatory requirements from the European Union Medical Devices Regulation (EU MDR) in relation to post-market clinical follow-up (PMCF).

NCT ID: NCT05297253 Completed - Clinical trials for Implant Complication

Prosthetic and Biological Complications of Implant Supported Prostheses

Start date: March 20, 2022
Phase:
Study type: Observational

complications of implant retained prostheses

NCT ID: NCT05168891 Recruiting - Peri-Implantitis Clinical Trials

"Surgical vs. Non-surgical Peri-implant Therapy"

Start date: February 20, 2022
Phase: N/A
Study type: Interventional

The aim of this randomized clinical trial is to evaluate the effectiveness, in terms of clinical and radiographic changes, of non-surgical peri-implant therapy (mechanical/chemical) versus regenerative surgical therapy (xenograft and collagen membrane), after a follow-up period of 12 months.

NCT ID: NCT04941612 Recruiting - Child, Only Clinical Trials

Use of the Bioabsorbable Activa IM-Nailâ„¢ in Pediatric Diaphyseal Forearm Fractures

Start date: May 25, 2021
Phase: N/A
Study type: Interventional

Background Pediatric diaphyseal forearm fractures are common and one of the most frequent reasons for orthopedic care. Fractures in need of surgery are often treated with metal Elastic Stable Intramedullary Nails (ESIN). Nail removal after 6-12 months is generally advocated. Surgical hardware removal has few complications; however, it is a substantial burden on the child, the family and healthcare economy. Bioabsorbable Intramedullary Nails (BIN) have been developed for the same indications as metal ESIN. The use of bioabsorbable implants would deem hardware removal unnecessary and relieve the child of further surgery and reduce healthcare costs. Methods The investigators aim to recruit all children in the catchment area of Herlev and Gentofte University Hospital (Copenhagen, Denmark) with acute unstable diaphyseal forearm fractures. Participants will be operated with BIN and followed consecutively for 2 years with interim analysis of data after 6 months. The investigators will report radiological healing using the Radiographic Union Score (RUS) 3 months after surgery together with any adverse events during follow-up. Discussion This study will provide important preliminary data and asses the feasibility of using the bioabsorbable Activa IM-Nailâ„¢ in pediatric diaphyseal forearm fractures. This study is a pilot study for initiating an RCT comparing BIN to metal ESIN hypothesizing that BIN is not an inferior treatment.

NCT ID: NCT04877145 Completed - Clinical trials for Implant Complication

Implant Placement Using a Newly Designed Single Drill Versus Conventional Sequential Drills

Start date: February 12, 2017
Phase: N/A
Study type: Interventional

dental implants are usually placed by sequential set of drills which could increase the time of the surgery and could raise the temperature of the osteotomy preparation so a new drill was designed to place the implants fast and easy way

NCT ID: NCT04805138 Completed - Clinical trials for Peri-implant Mucositis

Influence of Soft Tissue Thickness Upon Dental Implant Esthetics

Start date: April 1, 2019
Phase:
Study type: Observational

Since the beginning of the implant dentistry, a large variety of materials have been used for restoring single or multiple implants, such as gold, titanium, alumina (Al2O3), and zirconia (ZrO2). Patient physical and esthetic requirements play one of the most important role in making decisions related to which material should be chosen. In fact, long-term stability, compatibility with oral tissues esthetics and costs should be considered. Several studies demonstrated that both titanium and zirconia have an excellent biocompatibility and long-term stability even though something could change in terms of esthetic outcomes. Related to esthetics, the color of the peri-implant mucosa is an essential factor that clinicians have to take in to account. Unfortunately, discoloration of peri-implant mucosa sometimes happens. Some authors hypothesized that titanium abutments could provoke a grayish appearance of the mucosa, and, in order to avoid this problem, other authors suggested to perform augmentation of the peri-implant soft tissue thickness in the esthetic area. A study on pig maxillae found that the type of abutment or crown material and the mucosa thickness have significant influences on color changes of the mucosa. Titanium induced the most prominent color change, and, in patients with thinner mucosa, zirconia induced the least noticeable color changes. Nowadays, to reliably evaluate differences in color in implantology, the most used method is spectrophotometry, due to the capacity of detecting even small color differences and due to the higher reproducibility. Several investigations on pig jaws using spectrophotometric measurements were carried out recently, with the aim of investigating the color changes. It was found that generally titanium abutment lead to a more pronounced discoloration; however, gingival thickness greater than 2 mm did not reveal any difference related to the type of abutments. In addition, an increase in mucosal thickness might minimize the discoloration. The only study on human patients revealed that the color of the peri-implant mucosa presents more dark, green and blue components compared to the natural gingiva. Soft tissue thickness appeared a crucial factor with respect to the spectrophotometrically measured degree of peri-implant mucosal discoloration, with a trend for less pronounced discolorations in patients with thick mucosa. Furthermore, the authors found that peri-implant mucosa was on average 0,5-0,7 mm thicker than natural gingiva. However, this study evaluated the thickness of the gingiva by means of CBCT, which could lead to some errors due to the superimposition of the lips and cheeks, as well as the tongue that occupies the most space of the oral cavity. Moreover, esthetics were evaluated by clinicians visually at a specific distance asking them if discoloration was visible or not visible. Furthermore, no questionnaire was given to patients to evaluate esthetics neither discomfort while brushing. Therefore, The objective of this cross-sectional study is to evaluate the influence of gingival thickness (GT) upon mucosal color (MC) around dental implants measured spectrophotometrically. A secondary goal is to evaluate the correlation between mucosal color changes and type of abutment material around dental implants.

NCT ID: NCT04769934 Recruiting - Clinical trials for Implant Complication

Impact of Implant Insertion Torque on Peri-implant Bone Level.

Start date: August 1, 2018
Phase:
Study type: Observational [Patient Registry]

Observational study with one single arm. The purpose of this study was to evaluate the impact of the insertion torque and of the implant stability on the marginal bone level changes for dental implants placed into healed ridges.

NCT ID: NCT04731025 Recruiting - Clinical trials for Implant Complication

Local Antibiotics for Breast Implants

BREAST-AB
Start date: January 27, 2021
Phase: Phase 3
Study type: Interventional

The BREAST-AB Trial is a multi-center, randomized, double blind, placebo-controlled trial investigating the efficacy of local application of gentamicin, vancomycin and cefazolin in decreasing all-cause implant explantation after breast reconstruction.

NCT ID: NCT04630691 Completed - Clinical trials for Diabetes Mellitus, Type 2

Posterior Narrow Diameter Implants in Hyperglycemic and Normo-glycemic Patients

Start date: December 1, 2012
Phase:
Study type: Observational

The aim of the present study was to compare the initial healing and long term performance of narrow diameter implants in patients with uncontrolled Diabetes mellitus type 2 (T2DM) and healthy individuals.

NCT ID: NCT04622852 Completed - Clinical trials for Proximal Humeral Fracture

Pegs for Osteofixation of Proximal Humeral Fractures

Start date: July 1, 2017
Phase:
Study type: Observational

Patients treated operative for Proximal humeral fractures with angular stable device (Philos plate or ALPS-PHP)